Cellectis - ADR

NASDAQ:CLLS   3:59:52 PM EDT
2.50
-0.12 (-4.57%)
5:10:00 PM EDT: $2.70 +0.20 (+8.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)179.38M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$3.1 Million
Adjusted EPS-$0.35
See more estimates
10-Day MA$2.57
50-Day MA$2.63
200-Day MA$2.39
See more pivots

Cellectis - ADR Stock, NASDAQ:CLLS

8, rue de la Croix Jarry, Paris, Ile-de-France 75013
France
Phone: +33.1.81.69.16.00
Number of Employees:
http://www.cellectis.com

Description

Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. Sourdive and Andr�© Choulika on February 20, 1999 and is headquartered in Paris, France.